Sacco, R.; Akintola, O.; Sacco, N.; Acocella, A.; Calasans-Maia, M.D.; Maranzano, M.; Olate, S.
The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature. Medicina 2023, 59, 968.
https://doi.org/10.3390/medicina59050968
AMA Style
Sacco R, Akintola O, Sacco N, Acocella A, Calasans-Maia MD, Maranzano M, Olate S.
The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature. Medicina. 2023; 59(5):968.
https://doi.org/10.3390/medicina59050968
Chicago/Turabian Style
Sacco, Roberto, Oladapo Akintola, Nicola Sacco, Alessandro Acocella, Monica Diuana Calasans-Maia, Massimo Maranzano, and Sergio Olate.
2023. "The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature" Medicina 59, no. 5: 968.
https://doi.org/10.3390/medicina59050968
APA Style
Sacco, R., Akintola, O., Sacco, N., Acocella, A., Calasans-Maia, M. D., Maranzano, M., & Olate, S.
(2023). The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature. Medicina, 59(5), 968.
https://doi.org/10.3390/medicina59050968
